[Federal Register Volume 87, Number 177 (Wednesday, September 14, 2022)]
[Notices]
[Pages 56427-56428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold an in-
person meeting. The meeting will be open to the public and public 
comment will be heard during the meeting.

DATES: The meeting will be held June 22-23, 2022. The confirmed meeting 
times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become 
available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
online at: http://www.hhs.gov/nvpo/nvac/meetings/index.html at least 
one week prior to the meeting. Pre-

[[Page 56428]]

registration is required for those who wish to attend the meeting or 
participate in public comment. Please register at http://www.hhs.gov/nvpo/nvac/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer at the Office of Infectious Disease and HIV/AIDS Policy, U.S. 
Department of Health and Human Services, Mary E. Switzer Building, Room 
L618, 330 C Street SW, Washington, DC 20024. Email: [email protected]. 
Telephone: 202-494-1719.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    The NVAC will hear presentations on COVID-19, monkeypox, influena, 
and polio vaccination, as well as vaccine safety, innovation, and gaps 
in rural vaccination coverage. Please note that agenda items are 
subject to change, as priorities dictate. Information on the final 
meeting agenda will be posted prior to the meeting on the NVAC website: 
http://www.hhs.gov/nvpo/nvac/index.html.
    Members of the public will have the opportunity to provide comment 
at the NVAC meeting during the public comment period designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit written 
comments in advance. Written comments should not exceed three pages in 
length. Individuals submitting comments should email their written 
comments or their request to provide a comment during the meeting to 
[email protected] at least five business days prior to the meeting.

    Dated: 08/22/2022.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary 
for Health.
[FR Doc. 2022-19849 Filed 9-13-22; 8:45 am]
BILLING CODE 4150-44-P